海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Predicting the Response of Treatment in Cardiomyopathy
- Idiopathic Dilated Cardiomyopathy
- Australia
- 2011-02-08
Not recruiting
- Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
- Ulcerative Colitis;Crohn's Disease
- Australia, United States
- 2011-01-27
Not recruiting
- Autologous Bone Marrow Transplantation for Premature Ovarian Insufficiency
- Premature Ovarian Failure
- Egypt
- 2016-05-18
Authorised
- This is a study to evaluate the long term safety of Tolvaptan in adults with chronic kidney disease.
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) MedDRA version: 20.0 Level: LLT Classification code 10036046 Term: Polycystic kidney, autosomal dominant System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Netherlands, Norway, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States
- 2014-09-30
Recruiting
- The pharmacokinetics of two natural broccoli sprout supplements in healthy adults.
- Pharmacokinetic study of a nutritional supplement in healthy adults, as a potential future therapy for the treatment of pre-eclampsia.
- Australia
- 2017-04-24
Not recruiting
- Phase IIa examination of the effect of oral dosing of NV-52 on surrogate markers of inflammatory bowel disease (IBD) in patients with stable disease but with a consistent abnormality in one or more surrogate marker.
- Crohn's disease and Ulcerative Colitis
- Australia
- 2007-11-29
Not Recruiting
- A study conducted in many hospitals, carried out in two groups of patients with advanced skin cancer who know that they are receiving the study medication and have previously received treatment for their advanced skin cancer and the disease has progressed since that treatment
- American Joint Committee on Cancer unresectable stage III or stage IV melanima and disease progression with subjects not harboring the V600E-BRAF mutation with disease progression following first line standard of care (cohort 1) or subjects harboring the V600E-BRAF mutation with disease progression following BRAF-V600E-targeted therapy (cohort 2). MedDRA version: 14.1 Level: PT Classification code 10025650 Term: Malignant melanoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Germany, United Kingdom, United States
- 2010-07-19
Not recruiting
- PROxIMO: Efficacy of proactive therapeutic drug monitoring and dose adjustment of infliximab based on point of care testing for inflammatory bowel disease
- Ulcerative Colitis;Crohn's Disease
- Australia
- 2016-08-04
Recruiting
- Reliability of Simple Sonographic Findings Acquired With Hand-held Apparatuses to Inform Obstetric Diagnosis
- Obstetric Complication;Vaginal Bleeding;Eclampsia Preeclampsia;Obstructed Labor;Antepartum Hemorrhage
- Sierra Leone
- 2019-02-25
Authorised
- A Phase 2 clinical study to evaluate the safety and efficacy of the study medication CO-1686 in subjects with Previously Treated EGFR Non-Small Cell Lung Cancer
- Previously treated NSCLC patients who have documented evidence of an activating mutation in the EGFR gene and have failed treatment with an EGFR inhibitor MedDRA version: 20.0 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, France, Germany, Hong Kong, Korea, Republic of, Netherlands, Spain, Switzerland, Taiwan, United Kingdom, United States
- 2014-04-09
Not Recruiting
- A study evaluating the effect of EVARREST™ Fibrin Sealant Patch as compared to Tachosil in controlling bleeding during cardivascular surgery
- subjects undergoing major aortic surgery, including ascending, arch, or descending aorta replacement, requiring adjunctive support for hemostasis at the anastomotic suture line;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
- Australia, Belgium, Japan, Russian Federation, United Kingdom, United States
- 2013-11-26
Not recruiting
- PK Study of Rifampicin Interactions With DMPA and Efaviranz in TB
- HIV-1 Infection;Tuberculosis;HIV-1 Infection;Tuberculosis;HIV-1 Infection;Tuberculosis
- Botswana, Kenya, South Africa, Zimbabwe
- 2015-03-17
Authorised
- A Study of Ramucirumab plus Docetaxel in Participants with Urothelial Cancer
- Locally advanced or unresectable or metastatic urothelial carcinoma who have had disease progression on or after one prior first-line platinum-based chemotherapy. br>MedDRA version: 18.0 Level: LLT Classification code 10064467 Term: Urothelial carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Democratic People's Republic of, Netherlands, Poland, Romania, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2015-03-11
Not recruiting
- A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
- Solid Tumors and Advanced Endometrial Cancer;Endometrial Cancer;Second-line Treatment;VEGF;Solid Tumors and Advanced Endometrial Cancer;Endometrial Cancer;Second-line Treatment;VEGF;Solid Tumors and Advanced Endometrial Cancer;Endometrial Cancer;Second-line Treatment;VEGF;Solid Tumors and Advanced Endometrial Cancer;Endometrial Cancer;Second-line Treatment;VEGF
- Brazil, Egypt, Italy, Korea, Republic of, New Zealand, Spain, United Kingdom, United States
- 2011-06-06
Not recruiting
- Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase
- Gaucher Disease;Gaucher Disease;Gaucher Disease;Gaucher Disease
- Australia, Canada, Israel, Serbia, Spain, United Kingdom, United States
- 2008-07-07
Not recruiting
- Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial
- Gaucher Disease;Gaucher Disease;Gaucher Disease;Gaucher Disease
- Australia, Canada, Chile, Israel, South Africa, Spain, United Kingdom, United States
- 2008-06-25
Not Recruiting
- Phase 3 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLC
- First-line treatment of metastatic NSCLC MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-11-07
Authorised
- Phase 3 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLC
- First-line treatment of metastatic NSCLC MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-11-02
Authorised
- Phase 3 Study of Pembrolizumab with and without Epacadostat as a second treatment after a platinum containing chemotherapy for recurring or metastatic bladder cancer
- Recurrent or Progressive Metastatic Urothelial Carcinoma in Patients who have Failed a First-Line Platinum-containing Chemotherapy Regimen for Advanced/Metastatic Disease MedDRA version: 20.0 Level: LLT Classification code 10064467 Term: Urothelial carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-10-25
Authorised
- Phase 3 Study of Pembrolizumab with and without Epacadostat as a second treatment after a platinum containing chemotherapy for recurring or metastatic bladder cancer
- Recurrent or Progressive Metastatic Urothelial Carcinoma in Patients who have Failed a First-Line Platinum-containing Chemotherapy Regimen for Advanced/Metastatic Disease MedDRA version: 20.0 Level: LLT Classification code 10064467 Term: Urothelial carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-10-19
